Your browser doesn't support javascript.
loading
Moxetumomab pasudotox as re-treatment for heavily-pretreated relapsed hairy cell leukemia.
Yurkiewicz, Ilana R; Coutre, Steve; Ghesquieres, Herve; Pastan, Ira; Kreitman, Robert J.
Afiliação
  • Yurkiewicz IR; Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Coutre S; Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Ghesquieres H; Department of Hematology, Hôpital Lyon Sud, Université Claude Bernard Lyon 1, Pierre Bénite, France.
  • Pastan I; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Kreitman RJ; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Leuk Lymphoma ; 62(11): 2812-2814, 2021 11.
Article em En | MEDLINE | ID: mdl-34030585
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Toxinas Bacterianas / Leucemia de Células Pilosas / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Toxinas Bacterianas / Leucemia de Células Pilosas / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article